Treatment allocation in patients with early-stage esophageal adenocarcinoma: Prevalence and predictors of lymph node involvement
- PMID: 27142247
- DOI: 10.1002/cncr.30040
Treatment allocation in patients with early-stage esophageal adenocarcinoma: Prevalence and predictors of lymph node involvement
Abstract
Background: In considering treatment allocation for patients with early esophageal adenocarcinoma, the incidence of lymph node metastasis is a critical determinant; however, this has not been well defined or stratified by the relevant clinical predictors of lymph node spread.
Methods: Data from the Surveillance, Epidemiology, and End Results database of the National Cancer Institute were abstracted from 2004 to 2010 for patients with early-stage esophageal adenocarcinoma. The incidence of lymph node involvement for patients with Tis, T1a, and T1b tumors was examined and was stratified by predictors of spread.
Results: A total of 13,996 patients with esophageal adenocarcinoma were evaluated. Excluding those with advanced, metastatic, and/or invasive (T2-T4) disease, 715 patients with Tis, T1a, and T1b tumors were included. On multivariate analysis, tumor grade (odds ratio [OR], 2.76; 95% confidence interval [95% CI], 1.58-4.82 [P<.001]), T classification (OR, 0.47; 95% CI, 0.24-0.91 [P =.025]), and tumor size (OR, 2.68; 95% CI, 1.48-4.85 [P = .001]) were found to be independently associated with lymph node metastases. There was no lymph node spread noted with Tis tumors. For patients with low-grade (well or moderately differentiated) tumors measuring <2 cm in size, the risk of lymph node metastasis was 1.7% for T1a (P<.001) and 8.6% for T1b (P = .001) tumors.
Conclusions: For patients with low-grade Tis or T1 tumors measuring ≤2 cm in size, the incidence of lymph node metastasis appears to be comparable to the mortality rate associated with esophagectomy. For highly selected patients with early esophageal adenocarcinomas, the results of the current study support the recommendation that local endoscopic resection can be considered as an alternative to surgical management when followed by rigorous endoscopic and radiographic surveillance. Cancer 2016;122:2150-7. © 2016 American Cancer Society.
Keywords: Barrett esophagus; early esophageal cancer; endoscopic mucosal surgical resection; esophageal adenocarcinoma; esophageal cancer.
© 2016 American Cancer Society.
Similar articles
-
Surgical Management of Early-Stage Esophageal Adenocarcinoma Based on Lymph Node Metastasis Risk.Ann Surg Oncol. 2018 Jan;25(1):318-325. doi: 10.1245/s10434-017-6238-z. Epub 2017 Nov 16. Ann Surg Oncol. 2018. PMID: 29147928
-
The prevalence of lymph node metastases in patients with T1 esophageal adenocarcinoma a retrospective review of esophagectomy specimens.Ann Surg. 2011 Feb;253(2):271-8. doi: 10.1097/SLA.0b013e3181fbad42. Ann Surg. 2011. PMID: 21119508
-
Treatment trends, risk of lymph node metastasis, and outcomes for localized esophageal cancer.J Natl Cancer Inst. 2014 Jul 16;106(7):dju133. doi: 10.1093/jnci/dju133. Print 2014 Jul. J Natl Cancer Inst. 2014. PMID: 25031273
-
Endoscopic and surgical resection of T1a/T1b esophageal neoplasms: a systematic review.World J Gastroenterol. 2013 Mar 7;19(9):1424-37. doi: 10.3748/wjg.v19.i9.1424. World J Gastroenterol. 2013. PMID: 23539431 Free PMC article. Review.
-
Epidemiology, Diagnosis, and Management of Esophageal Adenocarcinoma.Gastroenterology. 2015 Aug;149(2):302-17.e1. doi: 10.1053/j.gastro.2015.04.053. Epub 2015 May 7. Gastroenterology. 2015. PMID: 25957861 Free PMC article. Review.
Cited by
-
Endoscopic therapy versus esophagectomy for T1bN0M0 esophageal cancer: A population-based study using propensity score matching.Heliyon. 2023 Nov 10;9(11):e22189. doi: 10.1016/j.heliyon.2023.e22189. eCollection 2023 Nov. Heliyon. 2023. PMID: 38045191 Free PMC article.
-
Role of endoscopic ultrasound for pre-intervention evaluation in early esophageal cancer.World J Gastrointest Endosc. 2023 Jun 16;15(6):447-457. doi: 10.4253/wjge.v15.i6.447. World J Gastrointest Endosc. 2023. PMID: 37397975 Free PMC article.
-
Influence of adverse effects of neoadjuvant chemoradiotherapy on the prognosis of patients with early-stage esophageal cancer (cT1b-cT2N0M0) based on the SEER database.Front Surg. 2023 Apr 17;10:1131385. doi: 10.3389/fsurg.2023.1131385. eCollection 2023. Front Surg. 2023. PMID: 37143768 Free PMC article.
-
A population-based investigation: How to identify high-risk T1-2N0 esophageal cancer patients?Front Surg. 2023 Jan 17;9:1003487. doi: 10.3389/fsurg.2022.1003487. eCollection 2022. Front Surg. 2023. PMID: 36733675 Free PMC article.
-
Barrett's esophagus: Review of natural history and comparative efficacy of endoscopic and surgical therapies.World J Gastrointest Oncol. 2022 Mar 15;14(3):568-586. doi: 10.4251/wjgo.v14.i3.568. World J Gastrointest Oncol. 2022. PMID: 35321279 Free PMC article. Review.
Publication types
MeSH terms
Supplementary concepts
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
